Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term

• Rubens C. Costa-Filho,
• Rubens C. Costa-Filho,
• José Paulo G. Leite,
• Marco Aurélio Horta,
• Felipe Gomes Naveca,
• Felipe Gomes Naveca,
• Felipe Saddy,
• Hugo C. Castro de Faria Neto,
• Hugo C. Castro de Faria Neto

Affiliations

Rubens C. Costa-Filho

Laboratory of Immunopharmacology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil

Rubens C. Costa-Filho

Estácio Medical School - IDOMED, Rio de Janeiro, Brazil

José Paulo G. Leite

Laboratory of Comparative and Environmental Virology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil

Marco Aurélio Horta

Biosafety Level 3 Platform (NB3), Rio de Janeiro, RJ, Brazil

Felipe Gomes Naveca

Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil

Felipe Gomes Naveca

Leônidas and Maria Deane Institute, Rio de Janeiro, Amazonas, Brazil

Felipe Saddy

Intensive Care Unit, Hospital Pró-Cardíaco, Rio de Janeiro, RJ, Brazil

Hugo C. Castro de Faria Neto

Laboratory of Immunopharmacology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil

Hugo C. Castro de Faria Neto

Faculdade de Medicina, Universidade Estácio de Sá, IDOMED, Rio de Janeiro, RJ, Brazil